Q3 Archives - FluoGuide A/S

22 August, 2025 Invitation to FluoGuide A/S (Nasdaq: FLUO) webcast on 28 August 2025 News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

FluoGuide A/S will publish its Interim Report Q2 2025 on Thursday 28 August 2025. The following event will take place later that day...

10 August, 2025 FluoGuide Q&A sessions highlight partnerships accelerating FG001 commercialization News English PR

Copenhagen, Denmark, 10 August 2025 – FluoGuide A/S is releasing a summary of its live-recorded interview at Redeye (English)...

31 July, 2025 Invitation: FluoGuide presentations on strategic collaborations and FG001 commercialization News English PR

FluoGuide is advancing its position in head and neck cancer treatment. On 21 July 2025, the company announced a strategic collaboration...

21 July, 2025 FluoGuide enters collaboration with global MedTech company Olympus News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English Regulatory MAR IR

Copenhagen, Denmark, 21 July 2025 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing...

3 July, 2025 Update on 2025 Outlook and Company progress News Corporate Action Other mfn-ext-nq mfn-ext-nq-corporate-action English IR

Copenhagen, Denmark, 3 July 2025 – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech...

10 June, 2025 FG001 clinical data in High-Grade Glioma is now published in Neurosurgery News Corporate Information Other Corporate Information mfn-ext-nq mfn-ext-nq-company-announcement English IR

Copenhagen, Denmark – FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused...

28 May, 2025 FluoGuide A/S publishes interim report for the period January – March 2025 - On track - first patients enrolled in CT-005 News English Regulatory Listing Regulation Report Interim Q1 IR

Copenhagen, Denmark, 28 May 2025 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results...

15 April, 2025 FluoGuide includes first patient in phase II trial of FG001 for head and neck cancer News Corporate Information Other Corporate Information English IR

Copenhagen, Denmark – FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision...

27 March, 2025 Minutes from Annual General Meeting in FluoGuide A/S News Corporate Information General meeting Report of the AGM English Regulatory Listing Regulation IR

Copenhagen, Denmark, 27 March 2025 – FluoGuide A/S (“FluoGuide” or the “Company” held its annual general...

2025

FluoGuideCalendar & events